Helping scientists and physicians publish their work for over 25 years
Comprehensive editing with word count reduction and UNLIMITED revisions until submission.
Learn MoreWhen is it useful to order an Analytical Review of your paper?
A common complaint of authors is that they have worked so long on their manuscript that they lose their overall perspective on it. They wonder, is the message of my paper coming across consistently, accurately, and clearly? Have I structured my paper properly? Have I included all the relevant details? Or have I included too much detail? Will the reviewers understand immediately how my study contributes significantly to the field? Have I made any glaring mistakes that will cause the journal editors and peer reviewers to view my manuscript unfavorably?
In such cases, it can be helpful to ask me to write an Analytical Review of your paper. This involves me first comprehensively editing your paper and then critically analyzing it according to a detailed list of criteria to identify areas that require improvement during revision, including:
The outcome of an Analytical Review is a report that starts with a summary of the study objective, design, key findings, and main conclusions. The report then notes all of the weaknesses and inconsistencies in the manuscript and provides recommendations on how to improve it. The report is sent to you along with the edited documents.
Price of an Analytical Review:
Are you interested in an Analytical Review of your paper after it is edited? If so, please go to the Order Form and tick the "Yes" box at the question "Would you like to order an Analytical Review?"
The ordering process is described in full in the Detailed ordering information page but here's a quick overview.
Choose whether the
best fits your needs
Complete the order form, including whether you
wish an Analytical Review of your work
Click SEND at the bottom of the order form
Within 24 hours, I will confirm your choices by email and
ask for the go-ahead to start work
On getting the go-ahead, I will edit your
manuscript
I will send you an email with the completed work
and instructions about how to pay
You can pay your invoice
by credit card, bank transfer,
Click here to learn more about the ordering process
OR
Click the button below to go to the Order Form
*I can also provide a voice recording of your conference talk in clear well-enunciated English so that you can practice your pronunciation, thus ensuring that your message is transmitted clearly during your talk. I do not have a conspicuous accent, having grown up with a melange of British, North American, Australian, European, Asian, and African accents.
Choose the package that is most suitable for you:
Or go directly to the order form:
Physicians have a large workload and sometimes would like help writing up their medical research. I have considerable experience in providing such a service, as you will see if you look at my papers.
This medical writing work can start from various points in the manuscript preparation process. For example, I can write the paper on the basis of the data analyses, the protocol/summary of the study objectives, and a list of relevant references.
Alternatively, the physician writes a rudimentary paper in the IMRAD format (Introduction-Methods-Results-and-Discussion) and I flesh it out into a well-argued and solid paper that is firmly grounded in the background literature and meets the relevant biomedical reporting guideline and journal requirements. A cover letter will also be provided and all data display items will be formatted according to journal guidelines. Figures can also be generated as needed.
The physician and his/her team is involved in every single step of the work I do. I may provide ideas for further analyses, directions, arguments, and/or appropriate journals. All decisions will be made by the client.
I also provide post-submission services, including writing rebuttal letters and revising the paper to address reviewer comments. I will continue working with you until your paper is published!
Cost depends on the requirements of the work. If you are interested in this service and would like a free quote, please contact me on SciMeditor@gmail.com.
Academic writing is difficult: extensive experience and strong language skills are needed to ensure that the key messages of your research are expressed clearly, accurately, and convincingly. Along with funding, English language proficiency is the most important factor that determines publication in high-ranking English language journals.1 SciMeditor is an excellent choice as your editor for many reasons, in particular:
I (the founder of SciMeditor) have a strong background in biomedical research, outstanding English language skills, and a strong commitment to excellence. I have clients based all over the world and extensive editing experience - over the last 20 years, I have edited:
* >3000 biomedical papers
* >400 reply-to-reviewer letters
* >100 NIH grant applications.
In the last decade:
* 41% of all papers I edited were published in the top 10% of journals in the field
* Mean (median) Journal IF of the publication journals = 3.918 (2.878)
* Mean (median) SNIP of the publication journals = 1.301 (1.131)
* Journals include The Lancet, Nature Medicine, Nature Communications, Annals of the Rheumatic Diseases, Gut, Cell Metabolism, PNAS, JEM, JACC...
* Average duration from first edit to publication = 6 months
* 91% of papers published in 12 months
Thus, I can help you to produce polished, concise, highly readable, and very clear manuscripts that stand an excellent chance of rapid publication in the best journal for your work. I guarantee you that your edited documents will not be rejected because of language or structural problems.
My extensive experience with my clients has led me to develop a variety of editing packages and services that will meet your every editing need as you move towards successful and career-affirming publication. Thus, you can choose between:
* Two turnover rates - regular (7 days) and express (72 hours)
* Two levels of editing - Basic and Comprehensive
* Two levels of FREE revision support - Comprehensive (one FREE re-edit) and Comprehensive PLUS (unlimited FREE re-edits until you have published).
Comprehensive PLUS is the most generous editing package on the web.
* My Analytical Review service can also show you how to further strengthen your manuscript before it goes for peer review.
I established SciMeditor to help researchers and physicians to achieve their aims, such as publishing their work in high-impact journals and obtaining research funds.
I am passionate about advancing the cause of science and medicine and feel that equitable global partnership that is unhindered by language difficulties will best achieve this ideal.
I have 11 years of experience in well-reputed scientific laboratories and more than 20 years of experience in editing and writing scientific and medical research manuscripts and other documents (>3000 manuscripts). I am committed to excellent science and will help you to produce elegant professional work that is clear, concise, accurate, and highly readable.
Your investment in my services will greatly improve your chances of rapid publication in high-quality journals and of receiving funding. My ultimate goal is to help you to pursue a long, impactful, and successful career.
CURRENT PROFESSION
Founder and Editor/Medical Writer of SciMeditor, 2002–present.
(i) Edited >4000 biomedical research papers and book chapters, >400 reply-to-reviewer letters, and >50 NIH grant applications.
(ii) Wrote >200 Analytical Reviews of research articles to guide revision before publication.
(iii) Wrote multiple papers with clients (see Research Publications below).
UNIVERSITY EDUCATION
PhD in Tropical Medicine and Immunology, 1990–1994. Thesis: CD4+ T-cell responses to the circumsporozoite proteins of Plasmodium falciparum and P. vivax by adults living in endemic and non-endemic regions of Thailand. Queensland Institute of Medical Research and University of Queensland, Brisbane, Australia. Field research was performed in the Research Institute of Health Sciences (RIHES), Chiang Mai, Thailand.
BSc (Honors) in Tropical Medicine and Immunology, 1989. Thesis: CD4+ T-cell responses to the circumsporozoite protein of Plasmodium falciparum by malaria-exposed Caucasians. Queensland Institute of Medical Research and University of Queensland, Brisbane, Australia.
Bachelor of Science, 1985–1988. Majors in Biochemistry and Zoology. University of Queensland, Brisbane, Australia.
PREVIOUS PROFESSIONAL EXPERIENCE
Postdoctoral fellow, 1998–2002. Netherlands Cancer Institute, Amsterdam, The Netherlands. Effect of expressing myelin basic protein in antigen-presenting cells on T-cell tolerance in experimental autoimmune encephalomyelitis.
Postdoctoral fellow, 1996–1998. Max-Planck Institute for Infection Biology, Berlin, Germany.
(1) Role of commensal Neisseria species in the development and progression of T-cell autoimmunity in rheumatoid arthritis and other arthritides.
(2) Development of vaccines against Helicobacter pylori.
Postdoctoral fellow, 1995. Queensland Institute of Medical Research, Brisbane, Australia. Effect of natural polymorphisms in immunodominant T-cell epitopes in the circumsporozoite protein of Plasmodium falciparum on peripheral blood T-cell responses.
RECENT EDUCATION
Workshops at European Medical Writers Association (EMWA) conferences 2011–2015, including:
Guide to key clinical documents | Documents from protocol to study report |
Writing the clinical study protocol | Writing clinical study reports using ICH E3 |
Subject narratives for medical writers | Good Clinical Practice (GCP) training |
Clinical study appendices | Drug safety for medical writers |
From clinical study report to manuscript | Medical devices |
Development Safety Update Reports | Grant writing |
Critical appraisal of medical literature | Analysis of variance and regression analysis |
Advanced epidemiology |
Obtained EMWA Professional Development Programme (EPDP) Certificate in Drug Development Writing in 2015.
RESEARCH PUBLICATIONS
My deep curiosity about the biomedical field led me to explore the immunology of four different medical fields during my 11 years in various labs - two infectious diseases and two autoimmune diseases. The insights I gleaned during this illuminating period continue to serve me well in my editing work on not only these diseases and the fundamental immunology field but also many other biomedical fields as well. I also write (or help write) papers for busy authors on the basis of their protocol and study data - this accounts for my most recent papers.
Perone J-M, Zevering Y, Clavieras C, Takka E, Retournay L, Goetz C. Effect of bilateral cataract surgery and implantation with four intraocular-lens combinations on visual quality of life and uncorrected binocular visual acuity: the ELVIRA-4 multicenter parallel-arm randomized clinical trial protocol. Submitted to BMC Public Health 2024.
Metz D, Gan G, Goetz C, Zevering Y, Moskwa R, Chaussard D, Bloch F, Vermion J-C, Perone J-M. Factors that predict graft detachment after DMEK: a retrospective study of 170 cases. Submitted to Scientific Reports 2024.
Perone J-M, Vermion J-C, Zevering Y, François J, Nessler A, Gan G, Goetz C. Evolution of intraocular pressure after cataract surgery in nonglaucomatous patients: a posthoc analysis of PERCEPOLIS clinical trial data and narrative review of the literature. Submitted to PLoS One 2024.
Lefevre S, Goetz C, Hennequin L, Zevering Y, Dinot V. Frequencies and predictors of subcutaneous and intraosseous injection with 4 epinephrine autoinjector devices. Ann Allergy Asthma Immunol. Published online May 11, 2024. doi:10.1016/j.anai.2024.05.002
Perone J-M, Goetz C, Zevering Y, Derumigny A. Principal Component Analysis of a Real-World Cohort of Descemet Stripping Automated Endothelial Keratoplasty and Descemet Membrane Endothelial Keratoplasty Cases: Demonstration of a Powerful Data-Mining Technique for Identifying Areas of Research. Cornea.():10.1097/ICO.0000000000003584, May 29, 2024. | DOI: 10.1097/ICO.0000000000003584
Perone J-M, Luc M-S, Zevering Y, Vermion JC, Gan G, Goetz C. Narrative review after post-hoc trial analysis of factors that predict corneal endothelial cell loss after phacoemulsification: Tips for improving cataract surgery research. PLoS One. 2024;19(3):e0298795.
Falgayrettes N, Patoor E, Cleymand F, Zevering Y, Perone J-M. Keratoconus may have a biomechanical etiology that is initiated in the posterior corneal stroma: two numerical studies. PLoS One. 2023. 18, e0278455.
Bichet O, Moskwa, R, Goetz C, Zevering Y, Vermion J-C, Perone J-M. Five-year clinical outcomes of 107 consecutive DMEK surgeries. PLoS One. 2023. 10.1371/journal.pone.0295434.
Perone J-M, Goetz C, Zevering Y. Letter Regarding: Corneal endothelial cell loss after endocapsular and supracapsular phacoemulsification: the PERCEPOLIS randomized clinical trial. Cornea. 2023. 10.1097/ICO.0000000000003305. PMID: 37154785.
Moskwa R, Bloch F, Vermion J-C, Zevering Y, Chaussard D, Nesseler A, Goetz C, Perone J-M. Postoperative, but Not Preoperative, Central Corneal Thickness Correlates With the Postoperative Visual Outcomes of Descemet Membrane Endothelial Keratoplasty. PLoS One. 2023. 3, e0282594.
Baudoin R, Vermion J-C, Bloch F, Zevering Y, Goetz C, Lhuillier L, Zaidi M, Perone J-M. 2022. Factors that influence endothelial cell injury during phacoemulsification: the PREDICS-pilot study. Submitted to Cornea 2024.
Gan G, Michel M, Max A, Sujet-Perone N, Zevering Y, Vermin J-C, Zaidi M, Savenkoff B, Perone J-M. Membranoproliferative glomerulonephritis after intravitreal vascular growth factor inhibitor injections: a case report and review of the literature. Br J Clin Pharm. 2022. doi: 10.1111/bcp.15558.
Malleron V, Bloch F, Zevering Y, Vermion J-C, Semler-Collery A, Goetz C, Perone J-M. Evolution of Corneal Transplantation Techniques and Their Indications in a Specialized French Ophthalmology Department in 2000–2020. PLoS ONE. 2022. 17:e0263686.
Chaussard D, Bloch F, Elnar AA, Zevering Y, Vermion JC, Moskwa R, Perone JM. Identification of the preoperative and perioperative factors that predict postoperative endothelial cell density after Descemet membrane endothelial keratoplasty: A retrospective cohort study. PLoS One. 2022;24;17:e0264401.
Giral JB, Bloch F, Sot M, Zevering Y, Elnar A, Vermion J-C, Goetz C, Lhuillier L, Perone J-M. Efficacy and safety of single-step transepithelial photorefractive keratectomy with the all surface laser ablation SCHWIND platform without mitomycin C for high myopia: a retrospective study of 69 eyes. PLoS One. 2021. doi:10.1371/journal.pone.0259993.
Perone J-M, Goetz C, Zevering Y, Derumigny A, Bloch F, Vermion J-C, Lhuillier L. Graft Thickness at 6 Months Postoperatively Predicts Long-Term Visual Acuity Outcomes of Descemet Stripping Automated Endothelial Keratoplasty for Fuchs Dystrophy and Moderate Phakic Bullous Keratopathy: A Cohort Study. Cornea. 2021 Oct 23. doi: 10.1097/ICO.0000000000002872.
Bloch F, Dinot V, Goetz C, Zevering Y, Lhuillier L, Perone J-M. Ability of routinely collected clinical factors that predict good visual results after primary Descemet membrane endothelial keratoplasty: a cohort study. BMC Ophthalmol. 2021. 22, 350.
Perone, J-M, Ghetemme C, Zevering Y, Zaidi M, Ouamara N, Goetz C, Lhuillier L. Corneal Endothelial Cell Loss After Endocapsular and Supracapsular Phacoemulsification. Cornea. 2021; 10.1097/ICO.0000000000002822
Poivret D, Goetz C, Zevering Y, Wilcke C, Noirez V. Effect of patient-led cooperative follow-up by general practitioners and community pharmacists on osteoporosis treatment persistence. Int J Rheum Dis. 2021; 24:912-921. doi: 10.1111/1756-185X.14146
Bellot A, Curien R, Derache A, Delaitre B, Longo R, Zevering Y, Guiilet J, Phulpin B. Oral management in a patient with Gardner-Diamond Syndrome: A case report. Int J Surg Case Reports. 2020. https://doi.org/10.1016/j.ijscr.2020.09.098
Piffer I, Goetz C, Zevering Y, Andre E, Bourouis Z, Blettner N. Ability of Emergency Department Physicians Using a Functional Autonomy-Assessing Version of the Triage Risk Screening Tool to Detect Frail Older Patients Who Require Mobile Geriatric Team Consultation. J Nutr Hlth Aging. 2020; 24:634-641. 10.1007/s12603-020-1378-4
Bischof F, Bins A, Dürr M, Zevering Y, Melms A, Kruisbeek AM. A structurally available encephalitogenic epitope of myelin oligodendrocyte glycoprotein specifically induces a diversified pathogenic autoimmune response. J Immunol. 2004; 173:600-6.
Bischof F, Wienhold W, Wirblich C, Malcherek G, Zevering O, Kruisbeek AM, Melms A. Specific treatment of autoimmunity with recombinant invariant chains in which CLIP is replaced by self-epitopes. Proc Natl Acad Sci U S A. 2001; 98:12168-73.
Zevering Y. Vaccine against Helicobacter pylori? Ann Med. 2001; 33:156-66. Review.
Zevering Y, Jacob L, Meyer TF. Naturally acquired human immune responses against Helicobacter pylori and implications for vaccine development. Gut. 1999; 45:465-74. [Review]
Zevering Y, Khamboonruang C, Good MF. Human and murine T-cell responses to allelic forms of a malaria circumsporozoite protein epitope support a polyvalent vaccine strategy. Immunology. 1998; 94:445-54.
Zevering Y, Khamboonruang C, Good MF. Effect of polymorphism of sporozoite antigens on T-cell activation. Res Immunol. 1994; 145:469-76. [Review]
Good MF, Zevering Y. Malaria-specific memory T cells: putative roles of different types of memory responses in immunity and disease. Res Immunol. 1994; 145:455-60. [Review]
Zevering Y, Khamboonruang C, Rungruengthanakit K, Tungviboonchai L, Ruengpipattanapan J, Bathurst I, Barr P, Good MF. Life-spans of human T-cell responses to determinants from the circumsporozoite proteins of Plasmodium falciparum and Plasmodium vivax. Proc Natl Acad Sci U S A. 1994; 91:6118-22.
Zevering Y, Khamboonruang C, Good MF. Natural amino acid polymorphisms of the circumsporozoite protein of Plasmodium falciparum abrogate specific human CD4+ T cell responsiveness. Eur J Immunol. 1994; 24:1418-25.
Good MF, Zevering Y, Currier J, Bilsborough J. 'Original antigenic sin', T cell memory, and malaria sporozoite immunity: an hypothesis for immune evasion. Parasite Immunol. 1993; 15:187-93.
Zevering Y, Amante F, Smillie A, Currier J, Smith G, Houghten RA, Good MF. High frequency of malaria-specific T cells in non-exposed humans. Eur J Immunol. 1992; 22:689-96.
Good MF, Zevering Y. Peptide analysis of the T cell response to the malaria circumsporozoite (CS) protein. Immunol Lett. 1990; 25:49-52.
Zevering Y, Houghten RA, Frazer IH, Good MF. Major population differences in T cell response to a malaria sporozoite vaccine candidate. Int Immunol. 1990; 2:945-55.
As a scientist who has worked and published in several very competitive fields, I understand how very important it is to safeguard your intellectual property from rivals. Your files are safe with me: all files that are sent to and from the SciMeditor website are fully encrypted by the website platform called Site123, and my computer is protected by Avast Premier and Secureline VPN. In addition, I no longer work in a lab and therefore have no conflicts of interest in relation to any work I receive. I am also the sole editor in SciMeditor: therefore, any work I receive through SciMeditor will only ever be seen by me. I assure you that I will never disclose to any third parties your name, your personal details, your contact information, or the content of any documents you send to me. However, if you would like a special confidentiality agreement, I am happy to accommodate that.
Naturally, if you are happy with my work, please feel free to recommend me to your colleagues or write a testimonial for publication on the Testimonials page of the SciMeditor website. In the case of the latter, I will not indicate any identifying details unless you have approved it in writing.
Naturally, I do collect, via the SciMeditor website and by email, personally identifiable information, namely, your name, e-mail address, and institutional information. This information is collected to facilitate communications with my clients, for quality assurance, and for billing purposes. This information will be stored indefinitely to ensure that future communications with you progress smoothly and rapidly. By entering your personally identifiable information on the Order Form, you warrant that I may store and use this information to facilitate further work with you.
When your work has been edited, I will return it to you by email with an invoice. Please pay within 30 days of receiving the invoice. The invoice will contain instructions on how to pay. There are two options:
Please note that when making a first payment with Stripe, your receipt will be sent to your email address 1 week after the transaction. This is because Stripe must first verify your credit.
It is very easy: review which of the three Editing Packages would best meet your needs and then go to the Order Form, complete your details, upload the files you want me to edit, and click SEND. Please ensure that all of the files you wish to send to me have been fully uploaded before you click SEND. Alternatively, you can contact me by email on SciMeditor@gmail.com. An overview of the ordering process is provided HERE. A detailed description of the ordering process is provided HERE.
Within 24 hours of you submitting the Order Form or an email to SciMeditor@gmail.com, you will receive an email from me. If I have no questions about your order, the email will ask you to give me the go-ahead via email to start working on your manuscript.
Yes, please! They greatly aid the editing work. If you ordered comprehensive editing, I will also edit them if they are in an editable format and check them closely to make sure they are consistent with the manuscript text that relates to them. Please also send the references because I use them when needed in my highly accurate Reference-based Editing approach.
You will receive an email from me with the edited work and the invoice.
I fully appreciate how important it is to safeguard your intellectual property. All files that are sent to and from the SciMeditor website are fully encrypted by the website platform Site123, and my computer is protected by Avast Premier and Secureline VPN, so your files are safe with me. I no longer work in a lab and therefore have no conflicts of interest in relation to any work I receive. Moreover, I am the sole editor in SciMeditor: therefore, any work I receive through SciMeditor will only ever be seen by me. Please see the following link for more information. If you would like a special confidentiality agreement, please email me on SciMeditor@gmail.com.
After your work has been edited, I will return it to you with an invoice. You can pay by credit card, bank transfer, or check. The necessary information for paying by all of these methods will be provided in the invoice. If you wish to pay by credit card, you can also do this from the How to pay page, which will send you to the encrypted PayPal site. Please pay within 30 days of receiving the invoice.
Yes. If you pay by credit card, you will be sent a payment receipt from PayPal. If you pay by bank transfer or check, I will send you a payment receipt by email.
I edit all types of biomedical documents, including journal manuscripts, grant proposals, books, abstracts, letters, cover letters, responses to referees, and rebuttal letters in the research fields of:
The Analytical Review Service provides an in-depth and detailed critical analysis of your paper. It serves as a before-peer review that picks up the weaknesses in the study report, so that you can address them before the peer reviewers see them. It is written after I have comprehensively edited the paper. It comes in the form of a report where I first check that a long list of criteria are met, including clear explanation of the study rationale, study design, and study limitations. The second part of the report lists the problems that could not be resolved during editing, such as lack of clarity about the key message of the paper, study objectives, and how the study contributes to the field. Key recommendations are provided. See this link for more information.
Yes. I edit according to the appropriate guideline and will inform you if any reporting elements are still missing after comprehensive editing.
You will receive two files: one that has the manuscript with the changes visible under Track Changes and one with all changes accepted to make the document easier to read. Track Changes is a feature of Microsoft Word and can be found by clicking the Review menu. When Track Changes is activated, all of the editing work in the manuscript is visible, including deletions and insertions. An example is given here. You can accept or reject changes by right clicking on the highlighted text and choosing the appropriate option from the pop-up menu.
An exception to these rules is if the manuscript has been so substantially altered that it bears little resemblance to the original manuscript. In this case, I may deem the work to be a new manuscript and will have to charge usual or discounted rates. Please see the SciMeditor policies page for more information.
If I have checked the paper in its entirety and no further changes have been made, I can provide a PDF editing certificate. I do not provide editing certificates for the Basic editing service because this service only provides basic language checks.
I do not routinely check for plagiarism but my Reference-based Editing approach means that I sometimes find sentences that are inadvertently similar to sentences in the cited publications. In this case, I paraphrase the sentences so that the key message is retained but the wording is different. I have never encountered a case of substantial plagiarism but if I did, I would return the paper to the authors asking them to rewrite the section in question. If you have any concerns, you can check your work with a plagiarism detection program, such as those provided by many institutions. Alternatively, you can check by placing individual sentences into Google.
I recommend to use journal finder programs. There are several free programs online. They include the Journal Finder from Elsevier, the Journal Suggester from SpringerNature, and JournalGuide, which gives journal recommendations across publishers. However, if you would like me to provide a journal recommendation report, please indicate this in the Order Form and I will provide you with a quote.
This package is suitable for well-written, fully comprehensible, and unambiguous papers that are ready for submission/re-submission pending light proof-reading. It corrects:
Spelling and punctuation errors
Grammatical mistakes
Unwieldy sentences
Re-edits of Basic Editing manuscripts are charged at a 50% DISCOUNT.
Click HERE to see an example of the Basic Editing service.
Prices for the Basic Editing package* | |
---|---|
Price per word Regular (7-day) | Price per word Express (72 hours) |
US$0.06 / €0.05 | US$0.07 / €0.06 |
*Euro prices may change depending on the exchange rate between US dollars and the Euro
To estimate how it will cost to edit your manuscript with the Basic Editing service, simply multiply the total number of words in your manuscript (without references) by the price per word shown above. For example, if your manuscript is 2000 words (without references), Basic Editing at the Regular rate will cost US$120 (2000xUS$0.06) or US$140 at the Express rate (2000xUS$0.07).
This package is suitable for any academic text written by researchers who are non-native speakers of English. It provides:
Careful and substantive editing, with text rewriting and reorganization (if required), to ensure:
One FREE re-edit
Reference-based Editing: where needed, I consult the cited reference. This ensures maximal fidelity to your intended meaning and can greatly improve the accuracy of the manuscript
Careful explanation in comments about why changes were made
Helpful comments, including about how to improve your manuscript further*
The manuscript contains the elements required by relevant biomedical study reporting guidelines (e.g. CONSORT, STROBE, ARRIVE etc.)
The requirements of the target journal or funding body are met, including American/British English usage, word counts**, format, and ethics, conflict of interest, funding, and other declarations
PDF Editing certificate
Click HERE to see an example of the Comprehensive Editing service.
Prices for the Comprehensive Editing package* | |
---|---|
Price per word Regular (7-day) | Price per word Express (72 hour) |
US$0.10 / €0.09 | US$0.14 / €0.125 |
*Euro prices may change depending on the exchange rate between US dollars and the Euro
To estimate how it will cost to edit your manuscript with the Comprehensive Editing service, simply multiply the total number of words in your manuscript (without references) by the price per word shown above. For example, if your manuscript is 2000 words (without references), Comprehensive Editing at the Regular rate will cost US$200 (2000xUS$0.10) or US$280 at the Express rate (2000xUS$0.14).
* Note that the Analytical Review Service provides an in-depth detailed analysis of the strengths and weakness of the manuscript.
** Word counts will be met unless the word count markedly exceeds the word count limit. At that point, further word count reduction becomes risky: I may inadvertently delete important information. Large word count reduction is also very time-consuming. In this case, I will inform you that the manuscript body exceeds the word count limit and that I advise you to revise the manuscript to reduce the word count.
This package is ideal for authors who desire ongoing support until submission. It offers ALL of the advantages of the Comprehensive Editing package AND
UNLIMITED FREE re-edits
Reducing the word count to meet journal/funding body requirements
FREE cover letter editing
Prices for the Comprehensive PLUS Ongoing Support Until Submission package* | |
---|---|
Price per word Regular (7-day) | Price per word Express (72 hour) |
US$0.17 / €0.15 | US$0.19 / €0.17 |
*Euro prices may change depending on the exchange rate between US dollars and the Euro
To estimate how it will cost to edit your manuscript with the Comprehensive PLUS Editing service, simply multiply the total number of words in your manuscript (without references) by the price per word shown above. For example, if your manuscript is 2000 words (without references), Comprehensive PLUS Editing at the Regular rate will cost US$340 (2000xUS$0.17) or US$380 at the Express rate (2000xUS$0.19).
(Note: I do not edit the references)
My editing goal is to ensure that the edited text faithfully conveys the author's intended meaning. However, sometimes, authors write statements that are very ambiguous.
For example: "There are thousands of patients with diagnosed multiple sclerosis every year and require TNFalpha treatment [ref1]."
This could be interpreted as "Thousands of patients are diagnosed with multiple sclerosis every year, many of whom eventually require TNFalpha treatment [ref1]" OR "Every year, thousands of patients who have been diagnosed with multiple sclerosis require treatment with TNFalpha [ref1]."
This kind of ambiguity impedes the smooth flow of concepts and can obscure the key messages of the manuscript. To eliminate it while ensuring high-fidelity editing, I use what I term Reference-based Editing. Thus, I will check the Abstract (or, if readily available, the online paper) of the cited text (in this case, ref1) to determine what the author means.
This approach also allows me to occasionally pick up referencing mistakes (such as citing the wrong paper) and to rewrite texts that resemble passages in the published paper too closely. The latter is a common inadvertent error made by authors who have difficulties writing in English but it can lead to rejection by the journal on the basis of plagiarism software, which many journals use routinely.
Reference-based Editing means that I can also offer versions of the original text that explain the point more precisely. For example, "Effort to improve antibiotic use has started a few years ago in Sri Lanka[ref9]". To improve this, I will check reference 9 and suggest to the author that the following reformulated sentence may be more suitable: "To improve antibiotic use in Sri Lanka, the government launched their first antibiotic stewardship program in 2011 [ref]."
Because I sometimes rely heavily on Reference-based Editing, I strongly encourage authors to supply the relevant bibliography.
Occasionally, even with Reference-based Editing, it is not possible to discern what the author means. In such cases, I will explain why the sentence is confusing and if possible, rewrite the text according to an educated guess: this rewritten text will be marked by an editor comment. I can sometimes also provide one or more alternatives in the comments: this allows the author to choose which version best captures their intended meaning.
Reports of biomedical studies such as randomized clinical trials, observational research studies, case series studies, in vivo animal studies, systematic reviews, and meta-analyses often lack detail regarding key elements of the study, such as its design, how patients were selected, and how key outcome variables are defined. This makes it difficult for time-poor reviewers and readers to quickly glean the essentials of the paper, assess the quality of the study, and compare it to similar studies.
Consequently, high-quality studies may be overlooked or misunderstood and may end up being published in less prestigious journals.
To address these problems, biomedical study reporting guidelines have been generated. They indicate the key reporting elements and the order in which these elements should be reported. Most reputable journals require adherence to these guidelines. They are listed in The Equator (Enhancing the QUAlity and Transparency Of health Research) Network and include:
I have extensive experience with these guidelines and adhere to them as much as possible during editing. I occasionally reorganize the Methods and Results sections so that they meet guideline requirements. I also indicate with editor comments where information required by the guideline is missing.
* I have constructed a simple version of STROBE that includes key elements in CONSORT: please click here.
Details of ordering a SciMeditor Editing package with or without an Analytical Review
First, go to the Editing Packages page and determine which of the three packages best meet your needs. If you want a detailed critical analysis of your manuscript, take a look at the Analytical Review Service.
Then go to the Order Form and choose the package and turnaround time that suits your needs. Upload all of the documents that you want to have edited. These files may include, for example, your study report, the cover letter, and the tables. Please also upload the figures and references because they greatly aid the editing work. The references will not be edited. The figures will be checked for errors and discrepancies.
You can also simply attach your documents to an email to SciMeditor@gmail.com that tells me which package and turnaround time you prefer.
Within 24 hours, I will review your order and reply to your email. If I have no questions, I will ask you to send me an email to SciMeditor@gmail.com confirming that I can start editing your work.
I will then edit your paper. Depending on the package chosen, I will edit for English language only (the Basic package) or comprehensively edit the manuscript so that the concepts flow clearly and smoothly, there are no discrepancies between sections, and the manuscript meets journal and/or other guidelines (the Comprehensive and Comprehensive PLUS packages). In the latter two packages, the ultimate aim is to produce a manuscript that is so clear that a lay scientist will rapidly and fully understand the significance of your work.
I use "Track Changes" in Word and add comments to explain why I made certain changes or to indicate where additional information is needed. Here is an example of comprehensive editing:
If you ordered an Analytical Review, I will complete the Analytical Review form after thoroughly editing the manuscript according to the selected Editing Package specifications.
I will then send you the edited work together with an invoice that explains how you can pay. You have the choice of paying by credit card, bank transfer, or check. You can also pay by going to the How to pay page in the SciMeditor website.
You should then accept the changes that you like in the edited manuscript and make any necessary clarifications.
If you chose the Comprehensive or Comprehensive PLUS package, you can send the revised manuscript back to me via email (SciMeditor@gmail.com). Please quote the original Job Number in your email. The re-edit in the Comprehensive package must be returned within 1 year of receipt of the first edited manuscript. There is no time limit on the re-edits in the Comprehensive PLUS package.
If you have any questions or problems at any point, please feel free to contact me on SciMeditor@gmail.com. I will do my best to help you.
The original text, which is relatively well written, looks like this:
After Basic Editing, the text looks like this:
After accepting all changes, the text looks like this:
The original text looks like this:
The text looks like this after Comprehensive editing:
Updated November 2018
Updated November 2018
Updated November 2018
Updated November 2018
My many years of editing experience have led me to identify four very common and unfortunately fatal mistakes that scientists and physicians make when they write their paper. These mistakes are so serious that you risk immediate rejection if you make even just one of them. Here I will describe one of these mistakes and show how you can avoid it.
FATAL MISTAKE 2: Unclear what the study adds to the body of knowledge
Example: study in human cadavers that examined the ability of a new rod and screw system to fuse lumbar vertebrae (L1-L5).
Introduction: describes the reasons for lumbar fusion. Does not mention other lumbar fusion methods.
Results: new system stably fuses L2 to L3, not so good with other pairs or more extensive fusions.
Discussion: discusses at length how to improve the system to make it more useful. No mention of how new system could compare to other existing systems.
HOW NOVEL IS THE NEW SYSTEM? WHAT DOES THE STUDY ADD TO THE FIELD?
Why is this a serious error?
Because papers should be written for a general audience and even specialists in the field will want some discussion about existing modalities.
How can you avoid this mistake?
After writing your paper, ask yourself: have I made clear how my study adds to the field in:
Abstract
Introduction
Discussion
Collect the texts on background on one page. Do these texts clearly present how the paper adds to the field?
My many years of editing experience have led me to identify four very common and unfortunately fatal mistakes that scientists and physicians make when they write their paper. These mistakes are so serious that you risk immediate rejection if you make even just one of them. Here I will describe one of these mistakes and show how you can avoid it.
FATAL MISTAKE 3: Not openly disclosing that your study is confirming/testing the findings of another study
Example: murine study on a new angiotension-converting enzyme (ACE) inhibitor in chronic kidney disease.
Introduction: “Several studies have shown that ACE inhibitors in CKD are effective [refs 5,6,8]”
Discussion: “A study similar to ours showed that [the new ACEi] is also effective for CKD [ref 5].”
Why is this a serious error?
Because it is annoying for a reviewer to find near the end of the paper that the study is not novel. In addition, confirmatory studies are an important part of science and are increasingly being respected as such: don't hide the confirmatory nature of your study.
How can you avoid this mistake?
After writing your paper, ask yourself: have I made it absolutely clear that my study aimed to test the reliability of the results of another similar study in:
Abstract
Introduction
Discussion
Conclusion
My many years of editing experience have led me to identify four very common and unfortunately fatal mistakes that scientists and physicians make when they write their paper. These mistakes are so serious that you risk immediate rejection if you make even just one of them. Here I will describe one of these mistakes and show how you can avoid it.
FATAL MISTAKE 4: Not clearly describing patient selection and comparator groups
Example: monocentric retrospective study comparing a nutrition program to standard care after radical surgery for advanced gastric cancer.
Methods: “This cohort study included patients with advanced non-metastatic gastric cancer who underwent radical surgery in 2014-2015.”
Results: “Patient characteristics are shown in Table 1. The nutrition program improved variables 1, 2, and 3 but not variables 4, 5, and 6.”
This paucity of information leaves the reader with many questions:
• Were the patients ALL CONSECUTIVE patients (or randomly selected, or a convenience series?)
• What were ALL the inclusion and exclusion criteria?
• How many patients were excluded, and for which reason? How did the nutrition-program and standard-care patients compare in terms of numbers excluded for certain criteria?
• How did the nutrition-program patients compare to the standard-care patients in terms of baseline and perioperative variables?
Why is this a serious error?
Because it is essential to disclose the information that will show if there is patient selection bias that could affect the interpretation and generalizability of your results.
How can you avoid this mistake?
By consulting the relevant biomedical study reporting guideline. In this example, STROBE would be appropriate. A randomized controlled trial would require CONSORT. The relevant guideline for your study can be found here. I have also constructed a simplified STROBE guideline that contains relevant CONSORT elements.
The text looks like this after Comprehensive editing:
These mistakes are very commonly made when authors write their scientific paper. They increase the risk of rejection, especially when many of these errors are present. The following table will list these mistakes, explain why they are problematic, and how they can be avoided.
In addition to the hints given here, I should point out that many of these mistakes can be avoided by checking the relevant study reporting guideline for the reporting structure and elements that your paper will need. I have also created a simplified guideline for reporting human observational studies that includes relevant STROBE and CONSORT guidelines.
Part of paper | The mistake | Comment | How to avoid this mistake |
ABSTRACT | 1. Abstract lacks one or more key elements
| The Abstract is the most read part of your paper. It is essential that it contains ALL of the key elements and messages of your paper. | Check that ALL elements required are included. CONSORT for Abstracts gives good guidelines for not just randomized controlled trials but also observational human studies in general |
INTRODUCTION, DISCUSSION, REVIEWS | 2. Studies cited in these literature-based papers/paper parts are not fully described (a) Type of study is unclear (e.g. RCT, cross-sectional, case report, in vitro, animal study, in silico study) | This makes it difficult for the reader to determine the quality of the evidence for the claim being made. Is it reliable (RCT, large prospective cohort study) or weak (case report, in vitro study?) | Check that the study type and its important elements are fully described |
(b) Type of subject unclear:
| This makes it difficult to see how comparable similar studies are | Check that the study type and its important elements are fully described | |
3. References are incorrect | This mistake is unnecessary and it gives the impression of sloppiness. That could make the reviewer distrust everything about the paper. | Check that all references are appropriate and correctly cited | |
4. References are not the ORIGINAL source of the data supporting the claim/statement in your paper | This can lead to unreflected dogmas in the field that have not actually been tested experimentally. These unchallenged dogmas can be quite destructive to the progression of science | Try as much as possible to make sure that the cited paper provides original data supporting the statement | |
5. Accidental plagiarism | This is because of copy and paste and then not reformulating. Copy-paste is a common technique for extracting information from the literature but if not rewritten, it is often clearly detectable to readers and may trigger journal plagiarism software | Put the copied-pasted text in a color and then, when revising the text, make sure that only one in three/four words remains that color | |
METHODS | 6. No/poor ethics section | Having a well-written and detailed ethics section gives the reader confidence that you understand the importance of ethics in biomedical science | All studies: "This study was approved by [the appropriate] ethics committee/institutional review board" Human studies: "This study adhered to the tenets of the Declaration of Helsinki and its revision"; "This study adhered to Good Clinical Practice guidelines"; "All patients provided written/oral informed consent to have their data included/ to participate in the study" Animal studies: "This study was conducted according to international [e.g. Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC International)], national, and/or institutional guidelines for humane animal treatment and complies with [relevant] legislation" |
7. Human study design not stated or incorrect (e.g. Cohort when it is cross-sectional) | Disclosing the study type helps the reader to quickly estimate the likely quality of your study findings. Not adding this information or using the wrong label may make the reviewer think that your understanding of study design could be limited | If unsure, consult the Equator Network to determine what type of study your study is | |
8. Not stated when the study in humans was conducted (e.g. January 2014-March 2015) | Was the study performed last year or two decades ago? This is particularly important for clinical studies because clinical practice can change very markedly over time | Make sure that you indicate when the study was performed in the Abstract and Methods | |
9. Experimental timelines unclear | e.g. when after the intervention did treatment start and when were samples taken? How long was follow-up? These experimental details should be described very clearly so that the reader knows how the experiment/study proceeded | Clearly describe these experimental details in the Abstract and Methods. Consider using a schematic depiction of the experimental timeline if multiple intervention timepoints and/or sampling timepoints are used | |
10. Detailing patient numbers in the Methods section e.g. “1022 patients were enrolled and 19 were excluded” | The Method section in human studies should only describe HOW the patients were selected | Only describe patient numbers in the Results section. Animal/well/cell numbers can be indicated in the Methods if the same number are used for all experiments. If varying animal/well/cell numbers are used, indicate this in the figure legends | |
11. Primary and secondary outcomes are unclear | The primary outcome MUST be clearly indicated because the power calculation determining the optimal study sample size should be based on being able to detect a a significant different regarding the primary outcome. This is often a confusing area in the Methods | Make sure to clearly distinguish between primary and secondary outcome measures in the Abstract and Methods | |
12. No power calculation | Does the study have enough power to detect a difference in primary outcome? Otherwise, the study is essentially useless | Consult a statistician to determine the optimal sample size. If necessary, a post-hoc analysis can be performed (but a priori power size calculations are better) | |
13. Statistics section incomplete/unused stats methods mentioned | This makes the reviewer think you do not understand your statistics | Make sure the Statistics section clearly explains ALL statistics you used and which analyses were performed | |
METHODS & RESULTS | 14. Use of uninformative experimental group names | e.g. Group 1, 2, and 3. The reader has to work hard to remember which is the control, which is intervention A, which is intervention B etc | Generally, group names are NOT needed. If absolutely necessary, use short, memorable, and completely distinguishable groups names |
15. Use of complicated experimental group names | e.g. a study in rats where the sciatic nerve is denervated surgically and then half of the rats start exercise training (ET) at 2 or 6 weeks. Groups are called Den2w, Den6w, Den2wET, Den6wET. It can be very confusing for the reader | Generally, group names are NOT needed. If absolutely necessary, use short, memorable, and completely distinguishable groups names | |
RESULTS | 16. Describing experiments that have not been mentioned in the Methods (or vice versa) | Many readers will quickly skim through the Methods before moving onto the Results. If an experimental method is suddenly mentioned in the Results but the method was not detailed in the Methods, this can confuse the reader | Make sure that all methods used to get the results are actually described in the Methods (and vice versa) |
17. Describing data that do not relate directly to the study objective. Often people do this because these data are not sufficient to write a whole paper about | e.g. cohort study examining whether 800 patients with rheumatoid arthritis on MTX mount good antibody responses to flu vaccine A. A subgroup of 20 patients is examined for T-cell responses to flu vaccine B antigen. The subgroup analysis will distract the reader from your main findings, disrupt the smooth flow of concepts, and cause confusion | Make sure that ALL data relate directly to the study question | |
18. Unclear how many patients/animals/wells per experiment, and how many times the experiment was performed | This is Science101 basic information that should always be included because it shows how reliable the findings are | Always indicate how many patients/animals/cells/wells were used for each experiment in the Results (human studies) or figure legends (other studies) | |
19. Inconsistencies between the Results section (and/or Abstract) and the data shown in the tables and figures | e.g. Results: “Of the 93 patients who received the study drug, seven (7.5%) had developed new-onset hypertension at 3 years.” Table 1: This kind of mistake is sloppy and can cause the reader to distrust your paper, especially when the p value is close to not being significant. The reader may become suspicious that the data were massaged | Always check that all data cited in the Abstract and Results match completely with the data in the figures and tables | |
DISCUSSION | 20. No Study Limitations section | No study is perfect - all have flaws e.g.
| It is essential that you are completely open about the limitations of your study. It makes you look very trustworthy and shows that you are really interested in answering the scientific question |